CLOFIBRATE-INDUCED NEOPLASTIC DEVELOPMENT IN THE RAT-LIVER IS ASSOCIATED WITH DECREASED CONNEXIN-32 EXPRESSION BUT NOT WITH A COORDINATED SHIFT IN EXPRESSION OF MARKER ENZYMES

Citation
H. Tsuda et al., CLOFIBRATE-INDUCED NEOPLASTIC DEVELOPMENT IN THE RAT-LIVER IS ASSOCIATED WITH DECREASED CONNEXIN-32 EXPRESSION BUT NOT WITH A COORDINATED SHIFT IN EXPRESSION OF MARKER ENZYMES, Toxicology letters, 82-3, 1995, pp. 693-699
Citations number
25
Categorie Soggetti
Toxicology
Journal title
ISSN journal
03784274
Volume
82-3
Year of publication
1995
Pages
693 - 699
Database
ISI
SICI code
0378-4274(1995)82-3:<693:CNDITR>2.0.ZU;2-E
Abstract
Altered enzyme phenotype and expression of connexin 32 (Cx32), a gap j unction protein were studied during the development of rat liver tumor s induced by the non-genotoxic carcinogen, clofibrate. (1) In contrast to previous findings for nitrosamine-induced lesions. preneoplastic e nzyme-altered foci (EAF) and neoplastic nodules (NN) lacked any clear association with degree of altered enzyme expression because of an alm ost complete negativity for GST-P and GGT. (2) Immunohistochemically d emonstrated Cx32 spots on the hepatocyte membranes showed a clear decr ease in clofibrate-induced lesions. (3) Naturally occurring EAF demons trating GST-P and/or GGT positivity did not show a significant decreas e of Cx32 counts suggesting a reversible nature. Therefore, the Cx32 d ecrease appears closely linked to progression of hepatocarcinogenesis irrespective of the enzyme phenotype of neoplastic focal lesions and t he carcinogens used for their induction.